vimarsana.com

Latest Breaking News On - Gwendolyn binder - Page 8 : vimarsana.com

Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201

Cabaletta Bio s (CABA) Buy Rating Reiterated at Guggenheim

Guggenheim reiterated their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research note released on Monday morning, Benzinga reports. Guggenheim currently has a $34.00 price objective on the stock. Separately, HC Wainwright raised their price target on Cabaletta Bio from $15.00 to $17.00 and gave the company a buy rating […]

Cabaletta Bio, Inc (NASDAQ:CABA) Receives Average Recommendation of Buy from Brokerages

Cabaletta Bio, Inc (NASDAQ:CABA) Receives Average Recommendation of Buy from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cabaletta Bio s (CABA) Buy Rating Reiterated at Guggenheim

Guggenheim reaffirmed their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report released on Monday, Benzinga reports. They currently have a $34.00 target price on the stock. Separately, HC Wainwright upped their target price on shares of Cabaletta Bio from $15.00 to $17.00 and gave the company a buy […]

Cabaletta Bio (NASDAQ:CABA) Price Target Raised to $17 00 at HC Wainwright

Cabaletta Bio (NASDAQ:CABA – Get Free Report) had its price target hoisted by HC Wainwright from $15.00 to $17.00 in a research report issued to clients and investors on Friday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 24.82% from […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.